Endoscopic resection of duodenal neuroendocrine tumors: A randomized controlled trial
Not Applicable
- Conditions
- Health Condition 1: K319- Disease of stomach and duodenum, unspecified
- Registration Number
- CTRI/2023/12/060494
- Lead Sponsor
- Asian institute of Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult patients (=18 years) with biopsy proven duodenal neuroendocrine tumors (DNETs)
2) Size of the lesion <15 mm
3) Absence of local and distant metastases (EUS and DOTANOC scan)
4) Willing to provide informed consent
Exclusion Criteria
1)Large lesions >15 mm
2)Invasion of muscularis layer and beyond on imaging (EUS)
3)Scarring or deformity in duodenum
4)Active duodenal ulcer
5)History of prior resection
6)Coagulopathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of histologically complete resection in both the armsTimepoint: 7 days
- Secondary Outcome Measures
Name Time Method Adverse EventsTimepoint: 7 Days;Procedure DurationTimepoint: 7 Days;Technical success: defined as en-bloc resection of the lesion without any residual lesion endoscopicallyTimepoint: 7 Days